RARE : Ultragenyx Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-06-20 |
|---|---|---|---|---|
| 2025 | $36.4 | $35.71 | $37.23 | -2.0% |
| 2026 | $36.55 | $35.7 | $39.05 | -1.59% |
| 2027 | $48.41 | $29.41 | $58.72 | 30.35% |
| 2028 | $32.6 | $13.06 | $50.41 | -12.23% |
| 2029 | $66.3 | $54.13 | $70.82 | 78.52% |
| 2030 | $45.88 | $30.05 | $68.22 | 23.52% |
| 2031 | $57.27 | $45.79 | $75.25 | 54.2% |
| 2032 | $52.86 | $26.18 | $77.85 | 42.34% |
| 2033 | $56.47 | $43.12 | $73.94 | 52.05% |
| 2034 | $65.22 | $31.7 | $80.58 | 75.6% |
| 2035 | $44.9 | $34.19 | $52.4 | 20.89% |
The 13 Wall Street analysts offering Ultragenyx Pharmaceutical stock forecast in the last 6 months have average price target of
$97.77 with a high forecast of $140.0 and a low forecast of $48.0.
The average Ultragenyx Pharmaceutical stock forecast represents a 163.25%
increase from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast for 2025, 6 predictions are offered for each month of 2025 with average Ultragenyx Pharmaceutical stock
forecast of $36.4, a high forecast of $37.23, and a low forecast of $35.71.
The average Ultragenyx Pharmaceutical stock forecast 2025 represents a -2.0%
decrease from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Ultragenyx Pharmaceutical stock
forecast of $36.55, a high forecast of $39.05, and a low forecast of $35.7.
The average Ultragenyx Pharmaceutical stock forecast 2026 represents a -1.59%
decrease from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Ultragenyx Pharmaceutical stock
forecast of $32.6, a high forecast of $50.41, and a low forecast of $13.06.
The average Ultragenyx Pharmaceutical stock forecast 2028 represents a -12.23%
decrease from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Ultragenyx Pharmaceutical stock
forecast of $45.88, a high forecast of $68.22, and a low forecast of $30.05.
The average Ultragenyx Pharmaceutical stock forecast 2030 represents a 23.52%
increase from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast 2031, 12 predictions are offered for each month of 2031 with average Ultragenyx Pharmaceutical stock
forecast of $57.27, a high forecast of $75.25, and a low forecast of $45.79.
The average Ultragenyx Pharmaceutical stock forecast 2031 represents a 54.2%
increase from the last price of $37.1399993896484.
For Ultragenyx Pharmaceutical stock forecast for 2035 (10 year), 6 predictions are offered for each month of 2035 with average Ultragenyx Pharmaceutical stock
forecast of $44.9, a high forecast of $52.4, and a low forecast of $34.19.
The average Ultragenyx Pharmaceutical stock forecast 2035 represents a 20.89%
increase from the last price of $37.1399993896484.
Please, see more forecasts below.
RARE : Ultragenyx Pharmaceutical stock forecast by Wall Street Analysts
The average Ultragenyx Pharmaceutical stock forecast from last 6 month is $97.77, and this show a 0.92% increase in average from the prior price target of the each prediction. Also, this average forecast of $97.77 represents a 2.71% increase from the past average forecast of $95.19, 6 months ago from 21 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-06-20 | Guggenheim | $64.0000 | $64.0000 | Buy |
| 2025-05-28 | William Blair | $65.0000 | Outperform | |
| 2025-05-09 | Morgan Stanley | $64.0000 | $65.0000 | Overweight |
| 2025-03-27 | JP Morgan | $104.0000 | $117.0000 | Overweight |
| 2025-03-17 | Piper Sandler | $140.00 | $115.0000 | Overweight |
| 2025-02-26 | Cantor Fitzgerald | $118.00 | $118 | Overweight |
| 2025-02-18 | HC Wainwright & Co. | $95.00 | $95 | Buy |
| 2025-02-18 | Canaccord Genuity | $121.0000 | $136.0000 | Buy |
| 2025-02-14 | HC Wainwright & Co. | $95.00 | $95.0000 | Buy |
| 2025-01-22 | Cantor Fitzgerald | $118.0000 | $118 | Overweight |
| 2025-01-13 | Wedbush | $46.00 | $48 | Neutral |
| 2025-01-13 | Piper Sandler | $135.0000 | $140 | Overweight |
| 2024-12-24 | HC Wainwright & Co. | $95.00 | $95 | Buy |
| 2024-12-20 | Wells Fargo | $75.00 | $88.0000 | Overweight |
| 2024-11-21 | JP Morgan | $105.0000 | $102.0000 | Overweight |
| 2024-11-12 | Canaccord Genuity | $121.0000 | $121.0000 | Buy |
| 2024-11-06 | HC Wainwright & Co. | $82.00 | $95 | Buy |
| 2024-11-06 | Cantor Fitzgerald | $116.00 | $116.00 | Overweight |
| 2024-11-06 | RBC Capital | $77.00 | $77.00 | Outperform |
| 2024-11-06 | Canaccord Genuity | $109.0000 | $121.0000 | Buy |
| 2024-10-22 | Cantor Fitzgerald | $116.00 | $116.00 | Overweight |
| 2024-10-21 | TD Cowen | $61.00 | $73.0000 | Buy |
| 2024-10-01 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-09-26 | RBC Capital | $77.00 | $77.00 | Outperform |
| 2024-09-20 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-09-16 | Cantor Fitzgerald | $116.00 | $116.0000 | Overweight |
| 2024-08-05 | Barclays | $83.0000 | $81.0000 | Overweight |
| 2024-08-02 | Wedbush | $43.0000 | $46 | Neutral |
| 2024-08-02 | Cantor Fitzgerald | $115.00 | $116 | Overweight |
| 2024-08-02 | Goldman Sachs | $67.00 | $76 | Buy |
| 2024-08-02 | Wells Fargo | $72.00 | $75.0000 | Overweight |
| 2024-07-23 | Canaccord Genuity | $111.00 | $111.0000 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $115.00 | $115.0000 | Overweight |
| 2024-07-18 | Wedbush | $45.0000 | $45 | Neutral |
Ultragenyx Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-06-23 | $36.82 | -0.86% |
| 2025-06-24 | $37.03 | 0.57% |
| 2025-06-25 | $37.28 | 0.68% |
| 2025-06-26 | $37.55 | 0.70% |
| 2025-06-27 | $37.43 | -0.31% |
RARE : Long term Ultragenyx Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Jul. is $37.23 , for 2026 Jun. is $36.04 , for 2029 Jun. is $67.99 , for 2030 Jun. is $35.48 , for 2034 Jun. is $77.91 , and for 2035 Jun. is $52.40.
RARE : Ultragenyx Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jul. | $37.23 | 0.24% |
| 2025 Aug. | $36.95 | -0.77% |
| 2025 Sep. | $36.54 | -1.11% |
| 2025 Oct. | $36.12 | -1.15% |
| 2025 Nov. | $35.84 | -0.76% |
| 2025 Dec. | $35.71 | -0.36% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $35.70 | -0.05% |
| 2026 Feb. | $35.73 | 0.10% |
| 2026 Mar. | $35.79 | 0.17% |
| 2026 Apr. | $35.86 | 0.20% |
| 2026 May. | $35.94 | 0.22% |
| 2026 Jun. | $36.04 | 0.29% |
| 2026 Jul. | $36.18 | 0.38% |
| 2026 Aug. | $36.39 | 0.59% |
| 2026 Sep. | $36.72 | 0.90% |
| 2026 Oct. | $37.21 | 1.34% |
| 2026 Nov. | $37.96 | 2.02% |
| 2026 Dec. | $39.05 | 2.86% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $40.54 | 3.81% |
| 2027 Feb. | $42.53 | 4.90% |
| 2027 Mar. | $45.06 | 5.96% |
| 2027 Apr. | $48.16 | 6.88% |
| 2027 May. | $51.78 | 7.50% |
| 2027 Jun. | $55.33 | 6.87% |
| 2027 Jul. | $57.97 | 4.77% |
| 2027 Aug. | $58.72 | 1.30% |
| 2027 Sep. | $56.92 | -3.07% |
| 2027 Oct. | $51.93 | -8.76% |
| 2027 Nov. | $42.58 | -18.01% |
| 2027 Dec. | $29.41 | -30.93% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $17.99 | -38.84% |
| 2028 Feb. | $13.06 | -27.42% |
| 2028 Mar. | $14.74 | 12.91% |
| 2028 Apr. | $20.50 | 39.07% |
| 2028 May. | $27.67 | 34.96% |
| 2028 Jun. | $33.71 | 21.83% |
| 2028 Jul. | $37.83 | 12.23% |
| 2028 Aug. | $40.53 | 7.14% |
| 2028 Sep. | $42.65 | 5.22% |
| 2028 Oct. | $44.78 | 5.00% |
| 2028 Nov. | $47.31 | 5.64% |
| 2028 Dec. | $50.41 | 6.56% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $54.13 | 7.38% |
| 2029 Feb. | $58.36 | 7.82% |
| 2029 Mar. | $62.42 | 6.95% |
| 2029 Apr. | $65.27 | 4.56% |
| 2029 May. | $66.94 | 2.56% |
| 2029 Jun. | $67.99 | 1.57% |
| 2029 Jul. | $68.92 | 1.37% |
| 2029 Aug. | $69.81 | 1.28% |
| 2029 Sep. | $70.49 | 0.98% |
| 2029 Oct. | $70.82 | 0.46% |
| 2029 Nov. | $70.64 | -0.24% |
| 2029 Dec. | $69.84 | -1.14% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $68.22 | -2.31% |
| 2030 Feb. | $65.53 | -3.95% |
| 2030 Mar. | $61.30 | -6.46% |
| 2030 Apr. | $54.73 | -10.72% |
| 2030 May. | $45.23 | -17.36% |
| 2030 Jun. | $35.48 | -21.55% |
| 2030 Jul. | $30.05 | -15.29% |
| 2030 Aug. | $30.13 | 0.26% |
| 2030 Sep. | $33.96 | 12.68% |
| 2030 Oct. | $38.74 | 14.09% |
| 2030 Nov. | $42.47 | 9.62% |
| 2030 Dec. | $44.66 | 5.15% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $45.79 | 2.54% |
| 2031 Feb. | $46.55 | 1.66% |
| 2031 Mar. | $47.44 | 1.90% |
| 2031 Apr. | $48.72 | 2.71% |
| 2031 May. | $50.54 | 3.73% |
| 2031 Jun. | $52.95 | 4.78% |
| 2031 Jul. | $55.97 | 5.71% |
| 2031 Aug. | $59.64 | 6.54% |
| 2031 Sep. | $63.88 | 7.12% |
| 2031 Oct. | $68.28 | 6.89% |
| 2031 Nov. | $72.23 | 5.79% |
| 2031 Dec. | $75.25 | 4.18% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $77.17 | 2.55% |
| 2032 Feb. | $77.85 | 0.88% |
| 2032 Mar. | $77.02 | -1.06% |
| 2032 Apr. | $74.23 | -3.63% |
| 2032 May. | $68.73 | -7.41% |
| 2032 Jun. | $59.20 | -13.87% |
| 2032 Jul. | $45.51 | -23.13% |
| 2032 Aug. | $32.87 | -27.76% |
| 2032 Sep. | $26.18 | -20.37% |
| 2032 Oct. | $26.39 | 0.82% |
| 2032 Nov. | $31.40 | 18.97% |
| 2032 Dec. | $37.82 | 20.45% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $43.12 | 14.00% |
| 2033 Feb. | $46.60 | 8.07% |
| 2033 Mar. | $48.66 | 4.43% |
| 2033 Apr. | $49.98 | 2.70% |
| 2033 May. | $51.19 | 2.42% |
| 2033 Jun. | $52.79 | 3.12% |
| 2033 Jul. | $55.05 | 4.28% |
| 2033 Aug. | $58.06 | 5.48% |
| 2033 Sep. | $61.82 | 6.47% |
| 2033 Oct. | $66.08 | 6.90% |
| 2033 Nov. | $70.37 | 6.49% |
| 2033 Dec. | $73.94 | 5.06% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $76.68 | 3.71% |
| 2034 Feb. | $78.74 | 2.69% |
| 2034 Mar. | $80.10 | 1.73% |
| 2034 Apr. | $80.58 | 0.59% |
| 2034 May. | $79.95 | -0.78% |
| 2034 Jun. | $77.91 | -2.55% |
| 2034 Jul. | $73.96 | -5.07% |
| 2034 Aug. | $67.28 | -9.03% |
| 2034 Sep. | $56.75 | -15.65% |
| 2034 Oct. | $44.16 | -22.18% |
| 2034 Nov. | $34.82 | -21.15% |
| 2034 Dec. | $31.70 | -8.97% |
RARE : Ultragenyx Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $34.19 | 7.87% |
| 2035 Feb. | $39.37 | 15.14% |
| 2035 Mar. | $44.42 | 12.84% |
| 2035 Apr. | $48.24 | 8.59% |
| 2035 May. | $50.77 | 5.25% |
| 2035 Jun. | $52.40 | 3.20% |
Financial Data for Ultragenyx Pharmaceutical stock
Frequently Asked Questions about Ultragenyx Pharmaceutical stock forecast
Is Ultragenyx Pharmaceutical a good long term stock?
From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2025 Jul. is $37.2309414854799 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2026 Jun. is $36.0441402180787 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2029 Jun. is $67.9887756526044 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock cannot be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2030 Jun. is $35.48036009177 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2034 Jun. is $77.9051549030959 From Ultragenyx Pharmaceutical stock forecast , Ultragenyx Pharmaceutical (RARE) stock can be a good investment choice. According to AIPickup, the Ultragenyx Pharmaceutical stock price forecast for 2035 Jun. is $52.3971226794597
Is Ultragenyx Pharmaceutical stock overvalued?
Ultragenyx Pharmaceutical (RARE) stock is expected to go DOWN . Therefore, AIPickup would say that Ultragenyx Pharmaceutical (RARE) stock is overvalued.
Will Ultragenyx Pharmaceutical stock price go up?
No. The Ultragenyx Pharmaceutical stock price forecast for 2026 Jun. is $36.0441402180787
Is Ultragenyx Pharmaceutical stock a good buy now?
Since closing price on 2025-06-20 is $37.1399993896484 and forecast for 2026 Jun. is $36.04, Ultragenyx Pharmaceutical stock is not a good 1 year investment.
14 Days Historical Data for Ultragenyx Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| RARE stock price for 2025-06-02 | $36.14 | $34.20 | $34.10 | $36.40 |
| RARE stock price for 2025-06-03 | $36.40 | $36.33 | $35.79 | $36.85 |
| RARE stock price for 2025-06-04 | $36.61 | $36.51 | $36.20 | $36.95 |
| RARE stock price for 2025-06-05 | $36.91 | $36.61 | $35.73 | $37.23 |
| RARE stock price for 2025-06-06 | $37.17 | $37.20 | $36.50 | $37.48 |
| RARE stock price for 2025-06-09 | $37.04 | $37.84 | $36.13 | $37.94 |
| RARE stock price for 2025-06-10 | $37.51 | $37.20 | $37.20 | $37.98 |
| RARE stock price for 2025-06-11 | $37.51 | $37.95 | $37.40 | $38.45 |
| RARE stock price for 2025-06-12 | $39.29 | $37.37 | $37.11 | $40.19 |
| RARE stock price for 2025-06-13 | $37.49 | $38.34 | $37.13 | $39.33 |
| RARE stock price for 2025-06-16 | $37.11 | $37.22 | $36.36 | $37.90 |
| RARE stock price for 2025-06-17 | $36.66 | $36.65 | $36.32 | $37.15 |
| RARE stock price for 2025-06-18 | $37.35 | $36.75 | $36.01 | $37.41 |
| RARE stock price for 2025-06-20 | $37.14 | $37.39 | $36.45 | $37.74 |